1-156134518-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PS1_ModeratePM1PM2PP2PP3_Moderate
The ENST00000368300.9(LMNA):c.629T>G(p.Ile210Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I210T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000368300.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.629T>G | p.Ile210Ser | missense_variant | 3/12 | ENST00000368300.9 | NP_733821.1 | |
LMNA | NM_005572.4 | c.629T>G | p.Ile210Ser | missense_variant | 3/10 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.629T>G | p.Ile210Ser | missense_variant | 3/12 | 1 | NM_170707.4 | ENSP00000357283 | P1 | |
LMNA | ENST00000677389.1 | c.629T>G | p.Ile210Ser | missense_variant | 3/10 | NM_005572.4 | ENSP00000503633 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 01, 2013 | Variant classified as Uncertain Significance - Favor Pathogenic. The Ile210Ser v ariant in LMNA has been reported in 1 individual with DCM and AFib (Parks 2008) and identified by our laboratory in 1 individual with DCM. In addition, function al studies have shown that this variant impacts protein function (Cowan 2010). H owever, this in vitro assay may not accurately represent biological function. Th is variant was absent from large population studies. Computational analyses (bio chemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) su ggest that this variant may impact the protein, though this information is not p redictive enough to determine pathogenicity. In summary, while the presence in a ffected individuals, functional studies, and low frequency all suggest that the Ile210Ser variant may be pathogenic, additional studies are needed to fully asse ss its clinical significance. - |
not provided Other:1
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at